ETON
HealthcareEton Pharmaceuticals, Inc.
$16.73
+$0.47 (+2.89%)
Jan 5, 2026
Price History (1Y)
Analysis
Eton Pharmaceuticals, Inc. is a healthcare company operating in the specialty and generic drug manufacturers sector. The company has a market capitalization of $448.66 million, annual revenue of $70.32 million, and employs 31 individuals. The company's financial health indicates mixed performance. Gross margin stands at 56.6%, while operating margin and profit margin are negative at -0.2% and -9.5%, respectively. Return on equity is -34.2%, but return on assets is 1.3%. The debt-to-equity ratio is high at 133.52, with cash totaling $37.12 million and debt of $30.88 million. The company's valuation context shows a forward P/E ratio of 16.56 and price to book of 19.41. Revenue growth has been significant, increasing by 117.5% year-over-year. However, earnings growth is not available for comparison.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Visit website →Key Statistics
- Market Cap
- $448.66M
- P/E Ratio
- N/A
- 52-Week High
- $23.00
- 52-Week Low
- $11.09
- Avg Volume
- 264.01K
- Beta
- 1.18
Company Info
- Exchange
- NGM
- Country
- United States
- Employees
- 31